VANGUARD FIDUCIARY TRUST CO
BankPosition in PTGX — Protagonist Therapeutics, Inc
CIK 933478
MALVERN, PA
Position in PTGX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$53,659,027
+$10,157,285 QoQ
Shares Held
437,747
+6.1% QoQ
Ownership
0.676%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#32
of 341 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PTGX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VANGUARD FIDUCIARY TRUST CO holds $5,564,871,787 across 467 Biotechnology names. PTGX ranks #24 (1.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,425,390 | $708,033,974 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
563,711 | $351,496,356 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
862,782 | $259,723,265 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
1,291,141 | $241,804,886 | |
| 5 | INSM |
INSMED Inc
|
1,401,552 | $149,433,474 | |
| 6 | MRNA |
Moderna, Inc.
|
1,987,627 | $139,193,518 | |
| 7 | RPRX |
Royalty Pharma plc
|
2,163,271 | $121,294,604 | |
| 8 | INCY |
Incyte Corp
|
943,540 | $106,959,694 |
All Filings in PTGX
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $53,659,027 | 437,747 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $43,501,742 | 412,730 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||